177 related articles for article (PubMed ID: 22940382)
1. Pre-existing virus-specific CD8(+) T-cells provide protection against pneumovirus-induced disease in mice.
van Helden MJ; van Kooten PJ; Bekker CP; Gröne A; Topham DJ; Easton AJ; Boog CJ; Busch DH; Zaiss DM; Sijts AJ
Vaccine; 2012 Oct; 30(45):6382-8. PubMed ID: 22940382
[TBL] [Abstract][Full Text] [Related]
2. Identification of a CD4 T cell epitope in the pneumonia virus of mice glycoprotein and characterization of its role in protective immunity.
Claassen EA; van Bleek GM; Rychnavska ZS; de Groot RJ; Hensen EJ; Tijhaar EJ; van Eden W; van der Most RG
Virology; 2007 Nov; 368(1):17-25. PubMed ID: 17632195
[TBL] [Abstract][Full Text] [Related]
3. Activation and inactivation of antiviral CD8 T cell responses during murine pneumovirus infection.
Claassen EA; van der Kant PA; Rychnavska ZS; van Bleek GM; Easton AJ; van der Most RG
J Immunol; 2005 Nov; 175(10):6597-604. PubMed ID: 16272314
[TBL] [Abstract][Full Text] [Related]
4. Animal model of respiratory syncytial virus: CD8+ T cells cause a cytokine storm that is chemically tractable by sphingosine-1-phosphate 1 receptor agonist therapy.
Walsh KB; Teijaro JR; Brock LG; Fremgen DM; Collins PL; Rosen H; Oldstone MB
J Virol; 2014 Jun; 88(11):6281-93. PubMed ID: 24672024
[TBL] [Abstract][Full Text] [Related]
5. Intranasal immunisation with recombinant adenovirus vaccines protects against a lethal challenge with pneumonia virus of mice.
Maunder HE; Taylor G; Leppard KN; Easton AJ
Vaccine; 2015 Nov; 33(48):6641-9. PubMed ID: 26529077
[TBL] [Abstract][Full Text] [Related]
6. CD8+ T-cell epitope mapping for pneumonia virus of mice in H-2b mice.
Walsh KB; Sidney J; Welch M; Fremgen DM; Sette A; Oldstone MB
J Virol; 2013 Sep; 87(17):9949-52. PubMed ID: 23824814
[TBL] [Abstract][Full Text] [Related]
7. The response of aged mice to primary infection and re-infection with pneumonia virus of mice depends on their genetic background.
Shrivastava P; Watkiss E; van Drunen Littel-van den Hurk S
Immunobiology; 2016 Mar; 221(3):494-502. PubMed ID: 26621546
[TBL] [Abstract][Full Text] [Related]
8. Depletion of alveolar macrophages prolongs survival in response to acute pneumovirus infection.
Rigaux P; Killoran KE; Qiu Z; Rosenberg HF
Virology; 2012 Jan; 422(2):338-45. PubMed ID: 22129848
[TBL] [Abstract][Full Text] [Related]
9. Pneumovirus-Induced Lung Disease in Mice Is Independent of Neutrophil-Driven Inflammation.
Cortjens B; Lutter R; Boon L; Bem RA; van Woensel JB
PLoS One; 2016; 11(12):e0168779. PubMed ID: 28005954
[TBL] [Abstract][Full Text] [Related]
10. Innate and adaptive immune response to pneumonia virus of mice in a resistant and a susceptible mouse strain.
Watkiss ER; Shrivastava P; Arsic N; Gomis S; van Drunen Littel-van den Hurk S
Viruses; 2013 Jan; 5(1):295-320. PubMed ID: 23337382
[TBL] [Abstract][Full Text] [Related]
11. Plasmacytoid dendritic cells promote host defense against acute pneumovirus infection via the TLR7-MyD88-dependent signaling pathway.
Davidson S; Kaiko G; Loh Z; Lalwani A; Zhang V; Spann K; Foo SY; Hansbro N; Uematsu S; Akira S; Matthaei KI; Rosenberg HF; Foster PS; Phipps S
J Immunol; 2011 May; 186(10):5938-48. PubMed ID: 21482736
[TBL] [Abstract][Full Text] [Related]
12. Role of T cells in virus control and disease after infection with pneumonia virus of mice.
Frey S; Krempl CD; Schmitt-Gräff A; Ehl S
J Virol; 2008 Dec; 82(23):11619-27. PubMed ID: 18815308
[TBL] [Abstract][Full Text] [Related]
13. IL-21 promotes the pathologic immune response to pneumovirus infection.
Spolski R; Wang L; Wan CK; Bonville CA; Domachowske JB; Kim HP; Yu Z; Leonard WJ
J Immunol; 2012 Feb; 188(4):1924-32. PubMed ID: 22238461
[TBL] [Abstract][Full Text] [Related]
14. Rhinovirus Reduces the Severity of Subsequent Respiratory Viral Infections by Interferon-Dependent and -Independent Mechanisms.
Van Leuven JT; Gonzalez AJ; Ijezie EC; Wixom AQ; Clary JL; Naranjo MN; Ridenhour BJ; Miller CR; Miura TA
mSphere; 2021 Jun; 6(3):e0047921. PubMed ID: 34160242
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of pneumonia virus of mice as a possible human pathogen.
Brock LG; Karron RA; Krempl CD; Collins PL; Buchholz UJ
J Virol; 2012 May; 86(10):5829-43. PubMed ID: 22438539
[TBL] [Abstract][Full Text] [Related]
16. Critical Adverse Impact of IL-6 in Acute Pneumovirus Infection.
Percopo CM; Ma M; Brenner TA; Krumholz JO; Break TJ; Laky K; Rosenberg HF
J Immunol; 2019 Feb; 202(3):871-882. PubMed ID: 30578308
[TBL] [Abstract][Full Text] [Related]
17. Efficient lung recruitment of respiratory syncytial virus-specific Th1 cells induced by recombinant bacillus Calmette-Guérin promotes virus clearance and protects from infection.
Cautivo KM; Bueno SM; Cortes CM; Wozniak A; Riedel CA; Kalergis AM
J Immunol; 2010 Dec; 185(12):7633-45. PubMed ID: 21084664
[TBL] [Abstract][Full Text] [Related]
18. Memory CD8 T cells mediate severe immunopathology following respiratory syncytial virus infection.
Schmidt ME; Knudson CJ; Hartwig SM; Pewe LL; Meyerholz DK; Langlois RA; Harty JT; Varga SM
PLoS Pathog; 2018 Jan; 14(1):e1006810. PubMed ID: 29293660
[TBL] [Abstract][Full Text] [Related]
19. Intranasal treatment with a novel immunomodulator mediates innate immune protection against lethal pneumonia virus of mice.
Martinez EC; Garg R; Shrivastava P; Gomis S; van Drunen Littel-van den Hurk S
Antiviral Res; 2016 Nov; 135():108-119. PubMed ID: 27771388
[TBL] [Abstract][Full Text] [Related]
20. Respiratory syncytial virus, pneumonia virus of mice, and influenza A virus differently affect respiratory allergy in mice.
Barends M; de Rond LG; Dormans J; van Oosten M; Boelen A; Neijens HJ; Osterhaus AD; Kimman TG
Clin Exp Allergy; 2004 Mar; 34(3):488-96. PubMed ID: 15005745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
